drugset / Trial / NCT04792749
Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of the study is to investigate the effects of metformin in addition to the conventional progestin therapy in the fertility-sparing treatment of early stage endometrial cancer.
Timeline
- Start
- 2021-06-01
- Primary completion
- 2023-12-31
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 2000 mg | Oral |